Cardiologist takes stand in Derek Chauvin trial, says George Floyd’s death was ‘absolutely preventable’

A cardiologist has taken the stand in Derek Chauvin’s murder trial for the death of George Floyd, sharing his opinion that Floyd’s death was “absolutely preventable.”

Chauvin is facing murder charges for his actions, which included kneeling on Floyd’s neck for nine minutes and 29 seconds while Floyd was lying face down. Jonathan D. Rich, MD, an associate professor of medicine at Northwestern Medicine in Chicago, testified April 12 that there were multiple instances when the former Minneapolis police officer could have repositioned Floyd and saved his life.

Rich testified that the initial way Chauvin restrained Floyd was the first such instance—and another was when an officer on the scene observed that Floyd was about to pass out.

“That would have been an opportunity to quickly relieve him from that position of not getting enough oxygen and perhaps turn him into a recovery position and allow him to start to expand his lungs again and bring in oxygen and get rid of carbon dioxide,” Rich said. “So, in addition to not putting him in that position in the first place, when there were signs that he was worsening, repositioning him—I think—very likely would have also saved his life.”

Video footage of Rich’s testimony is available here.

Click here for additional coverage of Chauvin’s trial, and Floyd’s death, from the Associated Press.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

One of the most formidable societies of medical professionals in the U.S. is going toe-to-toe with Robert F. Kennedy’s HHS over changing vaccination recommendations. 

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.